Pricing Log in Create free account

Aura Biosciences, Inc. (AURA) vs Ginkgo Bioworks Holdings, Inc. (DNA)

Aura Biosciences, Inc. and Ginkgo Bioworks Holdings, Inc. are both Biotechnology companies. Aura Biosciences, Inc. and Ginkgo Bioworks Holdings, Inc. are of similar size ($670.7M and $657.5M). Aura Biosciences, Inc. has the higher net margin (0.00% vs −260.0%) and the higher return on invested capital (0.00% vs −161.9%). Across the 13 metrics below, Aura Biosciences, Inc. leads on 9 and Ginkgo Bioworks Holdings, Inc. on 4.

Valuation

Metric AURA DNA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.21 9.40
P/B 1.97 1.65 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 4.05 9.02
Earnings yield (26.68%) (44.77%) (32.88%)
Free cash flow yield (16.61%) (25.07%) (23.13%)

Profitability

Metric AURA DNA Biotechnology median
Gross margin 0.00% 80.55% 68.51%
Operating margin 0.00% (273.61%) 0.00%
Net margin 0.00% (259.96%) 0.00%
Free cash flow margin 0.00% (155.75%) 0.00%
Return on equity (53.49%) (56.29%) (51.96%)
Return on assets (47.42%) (26.19%) (46.06%)
Return on invested capital 0.00% (161.94%) 0.00%

Growth

Metric AURA DNA Biotechnology median
Revenue growth (TTM) — (51.54%) 6.76%
EPS growth (last fiscal year) (0.57%) 46.49% 29.88%
Revenue growth, 5-year CAGR — 17.29% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA DNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.82 4.57 4.97
Net debt to EBITDA 1.29 1.63 1.01

Dividend

Metric AURA DNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AURA DNA Biotechnology median
Market cap 657.49m 670.71m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack